Deltex Medical (LON:DEMG) has added a twelfth US customer for its oesophageal Doppler monitoring system (ODM).
The unnamed hospital in the mid-west of the US has committed to taking at least 65 probes, used to test blood flow in real time, per month.
It is the first account in the Great Lakes sales territory which was set up in the first quarter.
It is the sixth deal of this type made in the US this year, and the twelfth in total.
Ewan Phillips, chief executive, said: “The US is an increasingly important market for us. Deltex Medical is making good progress towards our current goal of 30 US hospitals on its platform programme by mid-2016.”